^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Neuroblastoma
    Drug:cyclophosphamide (Alkylating agent)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    Source:
    FDA
    Published date:
    07/30/2020
    Excerpt:
    Cyclophosphamide is an alkylating drug indicated for treatment of...Malignant Diseases...neuroblastoma...